« Return to News | CROs/Service Providers

Quintiles Acquires Targeted Molecular Diagnostics

Monday, December 1, 2008 09:15 AM

Global contract research organization (CRO) Quintiles has acquired Westmont, Ill.-based Targeted Molecular Diagnostics (TMD), a specialty diagnostic laboratory focused on oncology.

The addition of TMD’s services will strengthen Quintiles’ capabilities in oncology, a fast-growing area for drug development.

“This acquisition is a logical addition to Quintiles’ service offerings,” said Tom Wollman, Senior Vice President, Quintiles Global Central Laboratories, in a company release. “It provides us with advanced in-house pathology capabilities, including telepathology. Most importantly, TMD’s knowledge in biomarker expression analysis adds significant new proficiencies sought by our customers.”

Quintiles did not provide specifics about the deal, but TMD president, CEO and founder Sarah Bacus said she and her team are eager to join Quintiles’ team.

Founded in 2004, TMD supports clinical trials for pharmaceutical and biotech sponsors in over 40 countries. The company supports the development of numerous targeted therapies in oncology and offers over 100 biomarker assays.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.